Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.01 (-1.40%)
Close on Nov 18, 2026Market cap $1.27MP/E –Yield –
Scinai Immunotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Scinai Immunotherapeutics's market cap was $2.90M on Nov 11, 2026, against $15.60M a year earlier. Over the last 5 years it ranged from $2.69M to $306.71M, with a median of $28.01M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.90M | -73.1% |
| 2025 | Dec 31, 2025 | $10.78M | -61.5% |
| 2024 | Dec 31, 2024 | $28.01M | +29.4% |
| 2023 | Dec 29, 2023 | $21.64M | -48.2% |
| 2022 | Dec 30, 2022 | $41.78M | -84.0% |
| 2021 | Dec 31, 2021 | $260.42M | +13.5% |
| 2020 | Dec 31, 2020 | $229.47M | -62.2% |
| 2019 | Dec 31, 2019 | $607.15M | +153.3% |
| 2018 | Dec 31, 2018 | $239.73M | +32.4% |
| 2017 | Dec 29, 2017 | $181.03M | +104.8% |
| 2016 | Dec 30, 2016 | $88.38M | – |
See a number that looks wrong?